A dish left too long
In September 1928, Alexander Fleming, a bacteriologist at St Mary’s Hospital in London, returned from a family holiday to find that one of his culture plates of Staphylococcus bacteria had been contaminated by a stray mould, and that the bacterial colonies nearest the mould had been destroyed while those further away grew normally. Rather than discard the plate, he investigated the mould itself, identified it as a species of Penicillium, and found that a substance in its broth could kill or inhibit a range of disease-causing bacteria even when heavily diluted. He named the substance penicillin, isolated it well enough to describe its antibacterial action, and published the finding in 1929, proposing that it might eventually prove useful in treating infection.
From petri dish to purified extract
Fleming’s own investigation went only so far: he grew the mould in pure culture, tested its broth against various bacteria, and established that it acted against gram-positive organisms such as staphylococci but not against gram-negative bacteria like those causing typhoid, work he presented to London’s Medical Research Club in February 1929. What he could not do, given the chemistry and equipment of the time, was purify enough stable penicillin to test it properly as a medicine, and the compound proved difficult to isolate, easily damaged, and hard to produce in any meaningful quantity. It took a separate team at Oxford’s Sir William Dunn School of Pathology, led by Howard Florey and Ernst Chain from 1940, to develop methods for concentrating and purifying penicillin well enough to demonstrate that it worked to cure infection in living animals, and then, cautiously, in human patients.
Killing bacteria, disease by disease
The core biological claim, that penicillin kills susceptible bacteria by disrupting the construction of their cell walls, has held up completely and underpins the entire class of related antibiotics developed since. Florey and Chain’s Oxford team confirmed the effect in mice and then, from 1941, in human patients, including a documented case in which a meningitis patient recovered fully in 1942 after treatment with purified penicillin. Fleming, Florey and Chain shared the 1945 Nobel Prize in Physiology or Medicine for the discovery and its development, and wartime industrial production in the United States, aided by a higher-yielding mould strain found on a cantaloupe in a Peoria market and by newly developed deep-tank fermentation methods, turned a laboratory curiosity into a drug manufactured on a large scale within a few years.
A decade of near-silence
Fleming’s original 1929 paper, on its own, did not establish penicillin as a usable medicine, and it sat largely unread for roughly a decade: even when he raised its potential at an international microbiology congress in 1936, the response was disbelief. The gap between observing an effect in a petri dish and delivering a reliable, purified, mass-produced drug was not something Fleming’s work closed; that required Florey and Chain’s purification chemistry and, separately, an American wartime industrial effort involving different institutions, different funding, and different scientists entirely. The original discovery also said nothing about how quickly and widely resistance would develop, a limitation that became apparent only once the drug was in wide use.
Scaling up for wartime medicine
Once mass production was achieved, penicillin became a documented factor in wartime medicine, credited with helping preserve a meaningful share of Allied soldiers who would otherwise have died or lost limbs to infected wounds, and it opened the modern era of antibiotic treatment for infections that had previously been reliably fatal or disabling. That same success created the problem Fleming himself foresaw: as penicillin use spread, some bacteria evolved enzymes, called penicillinases, that break down the drug before it can act, and resistant strains, including forms of Staphylococcus aureus that no longer respond to related antibiotics, have since become a serious and ongoing challenge in medicine, one traceable directly back to the mechanism this original discovery revealed.
A warning issued at the moment of triumph
This is worth understanding as a complete story rather than a single eureka moment, because the interesting part is not only the contaminated petri dish but everything that had to happen afterward, a decade of neglect, a separate team solving the purification problem, and a wartime industrial effort turning grams into tonnes, before the discovery meant anything to a patient. Fleming’s own warning, delivered in his Nobel lecture the same year the drug reached wide use, that underdosing or incomplete courses would breed resistant bacteria, adds a note of foresight that the subsequent history of antibiotic resistance has borne out closely. An hour with the full sequence explains as much about how discoveries become medicines as it does about penicillin itself.